Showing results (311-320 of 319) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 319 results.
Scientific Reports|August 10, 2019
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant ChemotherapyAnnamaria Ruzzo, Francesco Graziano, Francesca Galli, et al.
Scientific Reports|February 2, 2020
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant ChemotherapyAnnamaria Ruzzo, Francesco Graziano, Francesca Galli, et al.
The American Journal of Gastroenterology|April 22, 2010
Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory processJ-Matthias Löhr, Ralf Faissner, Dirk Koczan, et al.
Scientific Reports|November 6, 2014
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patientsAnnamaria Ruzzo, Francesco Graziano, Fabio Galli, et al.
Vaccine|November 3, 2009
The preventive phase I trial with the HIV-1 Tat-based vaccineBarbara Ensoli, Valeria Fiorelli, Fabrizio Ensoli, et al.
DNA and Cell Biology|October 25, 2002
HIV-1 Tat-based vaccines: from basic science to clinical trialsEmanuele Fanales-Belasio, Aurelio Cafaro, Andrea Cara, et al.
The Lancet. Neurology|August 16, 2024
Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trialStefan Zielen, Thomas Crawford, Luca Benatti, et al.
Retrovirology|May 1, 2015
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trialFabrizio Ensoli, Aurelio Cafaro, Anna Casabianca, et al.
Plos One|November 16, 2012
HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodiesPaolo Monini, Aurelio Cafaro, Indresh K Srivastava, et al.
Pageof 32